Health Care & Life Sciences » Pharmaceuticals | Wakamoto Pharmaceutical Co. Ltd.

Wakamoto Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
10,318
10,613
11,194
10,833
10,901
10,742
Cost of Goods Sold (COGS) incl. D&A
4,767
4,839
4,985
5,047
4,884
4,692
Gross Income
5,551
5,774
6,209
5,786
6,017
6,050
SG&A Expense
5,421
5,671
6,126
5,699
6,090
6,441
EBIT
126
103
83
87
73
391
Unusual Expense
1,007
7
21
2
49
57
Non Operating Income/Expense
248
135
31
90
202
220
Interest Expense
23
15
10
6
3
2
Pretax Income
1,359
232
126
170
174
230
Income Tax
514
148
106
75
48
49
Consolidated Net Income
845
83
21
95
126
181
Net Income
845
83
21
95
126
181
Net Income After Extraordinaries
845
83
21
95
126
181
Net Income Available to Common
845
83
21
95
126
181
EPS (Basic)
24.30
2.40
0.59
2.73
3.63
5.22
Basic Shares Outstanding
35
35
35
35
35
35
EPS (Diluted)
24.30
2.40
0.59
2.73
3.63
5.22
Diluted Shares Outstanding
35
35
35
35
35
35
EBITDA
836
873
832
763
464
80
Other Operating Expense
4
-
-
-
-
-
Non-Operating Interest Income
-
1
1
1
1
-

About Wakamoto Pharmaceutical Co.

View Profile
Address
2-2-2 Nihonbashi Hon-cho
Tokyo Tokyo 103
Japan
Employees -
Website http://www.wakamoto-pharm.co.jp
Updated 07/08/2019
Wakamoto Pharmaceutical Co., Ltd. engages in the manufacture and sale of ethical and non-prescription drugs. Its operations are carried out through the following segments: Medicine, Non-Prescription Drugs, Special Sales and Others. The Medicine segment provides ethical drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.